ALKEM LABORATORIES
Back to Balance Sheet
|
ALKEM LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-1,804 Cr | ₹-1,738 Cr | ₹-1,515 Cr | ₹-1,303 Cr | ₹-1,309 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of ALKEM LABORATORIES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹-1,804 Cr |
| Mar2025 | ₹-1,738 Cr |
| Mar2024 | ₹-1,515 Cr |
| Mar2023 | ₹-1,303 Cr |
| Mar2022 | ₹-1,309 Cr |
How is Deferred Tax Assets / Liabilities of ALKEM LABORATORIES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-1,804 Cr | Negative | |
| Mar2025 | ₹-1,738 Cr | Negative | |
| Mar2024 | ₹-1,515 Cr | Negative | |
| Mar2023 | ₹-1,303 Cr | Negative | |
| Mar2022 | ₹-1,309 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of ALKEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALKEM LABORATORIES | ₹64,554.1 Cr | 0.3% | -3.7% | 1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,090.0 Cr | 1% | -2.7% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,976.0 Cr | 0.7% | 17.1% | 40.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,639.0 Cr | -0.3% | -3.7% | 37.9% | Stock Analytics | |
| CIPLA | ₹115,216.0 Cr | -0.3% | 2.3% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | -1.4% | 0.7% | -6.2% | Stock Analytics | |
ALKEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALKEM LABORATORIES | 0.3% |
-3.7% |
1% |
| SENSEX | -0.6% |
1% |
-3.7% |
You may also like the below Video Courses